Table 1.
Patient demographics, nodal stage at presentation and initial evaluation
| ALND + WBRT n=25 |
MRM n=13 |
P Value | ||
|---|---|---|---|---|
| Demographics | Age, years, median | 59 | 53 | 0.878 |
|
| ||||
| Clinical Presentation | N1 | 22 (88%) | 10 (77%) | 0.392 |
|
| ||||
| N2/3 | 3 (12%) | 3 (23%) | ||
|
| ||||
| Systemic Staging | CT and Bone Scan | 9 (36%) | 3 (23%) | 0.773 |
|
| ||||
| Bone scan alone | 1 (4%) | 0 | ||
|
| ||||
| CT alone | 1 (4%) | 0 | ||
|
| ||||
| PET CT | 14 (56%) | 10 (77%) | ||
|
| ||||
| Biopsy Type | Excisional | 13 (52%) | 5 (38%) | 0.506 |
|
| ||||
| Needle Biopsy | 12 (48%) | 8 (62%) | ||
|
| ||||
| Additional biopsy following MRI | 3 (12%) | 2 (15%) | 1.000 | |
|
| ||||
| Biopsy Pathology | CK-7 Pos (n=29 tested) | 18 90%) | 9 (100%) | 1.000 |
|
| ||||
| CK-20 Pos (n=26 tested) | 0 | 0 | – | |
|
| ||||
| Grade 3 | 23 (92%) | 13 (100%) | 0.538 | |
ALND, axillary lymph node dissection; WBRT, whole-breast radiation therapy; MRM, modified radical mastectomy; CT, computed tomography; PET, positron emission tomography